GDRX
Goodrx Holdings Inc-Class A
NASDAQ · Health Care
$2.44
+0.15 (+6.55%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 685.76M | 671.92M | 331.62M | 348.02M | 354.36M |
| Net Income | 14.19M | 12.51M | 31.94M | 28.69M | 32.45M |
| EPS | — | — | — | — | — |
| Profit Margin | 2.1% | 2.0% | 9.6% | 8.2% | 9.2% |
| Rev Growth | +2.1% | +2.1% | -6.6% | +17.9% | +14.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 167.39M | 167.39M | 302.98M | 344.40M | 295.15M |
| Total Equity | 246.71M | 246.71M | 668.41M | 683.48M | 611.71M |
| D/E Ratio | 0.68 | 0.68 | 0.45 | 0.50 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 113.07M | 105.24M | 55.53M | 58.27M | 51.67M |
| Free Cash Flow | — | — | 25.99M | 25.71M | 22.62M |